We could not find any results for:
Make sure your spelling is correct or try broadening your search.
MIRA Pharmaceuticals, Inc. operates as a clinical development stage biopharmaceutical company. The company focuses on the development and commercialization of a new molecular synthetic tetrahydrocannabinol (THC) analog under investigation for the treatment of adult patients with anxiety and cognitiv... MIRA Pharmaceuticals, Inc. operates as a clinical development stage biopharmaceutical company. The company focuses on the development and commercialization of a new molecular synthetic tetrahydrocannabinol (THC) analog under investigation for the treatment of adult patients with anxiety and cognitive decline typically associated with early-stage dementia. It is developing MIRA1a, a synthetic cannabinoid analog to treat anxiety and chronic pain by targeting the cannabinoid type 1 and type 2 receptors. The company was formerly known as MIRA1a Therapeutics, Inc. MIRA Pharmaceuticals, Inc. was incorporated in 2020 and is headquartered in Baltimore, Maryland. Show more
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0.06 | 5.26315789474 | 1.14 | 1.33 | 1.1 | 267062 | 1.20075615 | CS |
4 | 0.03 | 2.5641025641 | 1.17 | 1.5 | 1.1 | 357402 | 1.29994183 | CS |
12 | -0.4864 | -28.8425047438 | 1.6864 | 1.7499 | 0.97 | 452194 | 1.28629508 | CS |
26 | -1.15 | -48.9361702128 | 2.35 | 2.7899 | 0.97 | 1360894 | 1.75982499 | CS |
52 | 0.2861 | 31.3053944633 | 0.9139 | 5.01 | 0.51 | 1967144 | 2.83288678 | CS |
156 | -5.8 | -82.8571428571 | 7 | 7.9799 | 0.51 | 1372338 | 2.85559475 | CS |
260 | -5.8 | -82.8571428571 | 7 | 7.9799 | 0.51 | 1372338 | 2.85559475 | CS |
Symbol | Price | Vol. |
---|---|---|
TCTMTCTM Kids IT Education Inc | US$ 0.764 (321.87%) | 731.1M |
NVDANVIDIA Corporation | US$ 120.07 (-3.67%) | 388.5M |
RIMEAlgorhythm Holdings Inc | US$ 0.02565 (5.12%) | 341.8M |
CLEUChina Liberal Education Holdings Ltd | US$ 0.1938 (30.77%) | 237.15M |
BHATBlue Hat Interactive Entertainment Technology | US$ 0.0355 (-11.25%) | 236.44M |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions